Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 45
Filtrar
1.
Leuk Lymphoma ; 59(1): 85-96, 2018 01.
Artigo em Inglês | MEDLINE | ID: mdl-28571522

RESUMO

We examined outcomes of 62 pediatric patients with relapsed or refractory non-Hodgkin lymphoma (rr-NHL) who underwent hematopoietic stem cell transplantation (HSCT). The overall survival (OS) and event-free survival (EFS) rates were 65% and 48%, respectively. Survival rates for patients with chemosensitive disease at the time of HSCT were significantly higher than those of patients with chemoresistant disease (69% vs. 37%, p = .019 for OS; 54% vs. 12%, p < .001 for EFS; respectively). A chemoresistant disease at transplantation was the only factor that predicted a limited OS (hazard ratio = 10.00) and EFS (hazard ratio = 16.39) rates. Intensive chemotherapy followed by HSCT could be an effective strategy for treating children with rr-NHL and may offer improved survival for a significant group of pediatric patients, particularly those with chemosensitive disease at transplantation.


Assuntos
Linfoma não Hodgkin/mortalidade , Linfoma não Hodgkin/patologia , Adolescente , Criança , Pré-Escolar , Resistencia a Medicamentos Antineoplásicos , Feminino , Transplante de Células-Tronco Hematopoéticas , Humanos , Linfoma não Hodgkin/epidemiologia , Linfoma não Hodgkin/terapia , Masculino , Estadiamento de Neoplasias , Prognóstico , Recidiva , Sistema de Registros , Estudos Retrospectivos , Fatores de Risco , Transplante Homólogo , Resultado do Tratamento , Turquia/epidemiologia
2.
J Infect Chemother ; 22(9): 617-21, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-27400951

RESUMO

AIM OF STUDY: Neutropenic fever is a source of morbidity and mortality in children with cancer. It is not possible to detect the causative agent in cultures in most cases; the research for a marker that can show the severity of the disease is ongoing. We evaluated the role of adrenomedullin (ADM) at predicting prognosis on patients with febrile neutropenia, which has been proven to be a good prognostic marker for diseases with high morbidity and mortality, such as heart failure, ischemic ventricular dysfunction, sepsis, and systemic inflammatory response syndrome. MATERIALS AND METHODS: We recorded the 36 febrile episodes of 14 children receiving chemotherapy due to solid tumors. There were 10 events with unknown origin in the low-risk group, while in the high-risk group, there were 17 events with unknown origin, 8 events with microbiological origin and 1 event with clinically proven infection. Cultures were positive only in the high-risk group. However, the changes of ADM levels through time periods (first, second, third, and seventh days) were not significant. RESULTS: The first-day plasma ADM levels significantly predicted the presence of culture positivity (AUC 0.628, 95% CI 0.40-0.85, p = 0.303) and high-risk patients with neutropenic fever (AUC 0.76, 95% CI 0.56-0.97, p = 0.016). CONCLUSION: Our study showed that increased plasma ADM was correlated with high-risk neutropenic fever and culture positivity. The ADM levels in the high-risk group were clearly high at the diagnosis and continued to the end of the treatment.


Assuntos
Adrenomedulina/sangue , Neutropenia Febril/sangue , Neoplasias/complicações , Adolescente , Antibacterianos/uso terapêutico , Biomarcadores/sangue , Criança , Pré-Escolar , Ensaio de Imunoadsorção Enzimática , Neutropenia Febril/tratamento farmacológico , Neutropenia Febril/microbiologia , Febre de Causa Desconhecida/sangue , Febre de Causa Desconhecida/tratamento farmacológico , Febre de Causa Desconhecida/microbiologia , Humanos , Prognóstico , Sensibilidade e Especificidade , Índice de Gravidade de Doença
4.
Turk J Haematol ; 33(4): 265-272, 2016 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-27094103

RESUMO

OBJECTIVE: The prognostic factors and a new childhood prognostic index after autologous hematopoietic stem cell transplantation (AHSCT) in patients with relapsed/refractory Hodgkin's lymphoma (HL) were evaluated. MATERIALS AND METHODS: The prognostic factors of 61 patients who underwent AHSCT between January 1990 and December 2014 were evaluated. In addition, the Age-Adjusted International Prognostic Index and the Childhood International Prognostic Index (CIPI) were evaluated for their impact on prognosis. RESULTS: The median age of the 61 patients was 14.8 years (minimum-maximum: 5-20 years) at the time of AHSCT. There were single relapses in 28 patients, ≥2 relapses in eight patients, and refractory disease in 25 patients. The chemosensitivity/chemorefractory ratio was 36/25. No pretransplant radiotherapy, no remission at the time of transplantation, posttransplant white blood cell count over 10x103/µL, posttransplant positron emission tomography positivity at day 100, and serum albumin of <2.5 g/dL at diagnosis were correlated with progression-free survival. No remission at the time of transplantation, bone marrow positivity at diagnosis, and relapse after AHSCT were significant parameters for overall survival. CONCLUSION: The major factors affecting the progression-free and overall survival were clearly demonstrated. A CIPI that uses a lactate dehydrogenase level of 500 IU/L worked well for estimating the prognosis. We recommend AHSCT at first complete remission for relapsed cases, and it should also be taken into consideration for patients with high prognostic scores at diagnosis.


Assuntos
Transplante de Células-Tronco Hematopoéticas , Doença de Hodgkin/mortalidade , Doença de Hodgkin/terapia , Adolescente , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Criança , Pré-Escolar , Terapia Combinada , Feminino , Doença de Hodgkin/diagnóstico , Doença de Hodgkin/epidemiologia , Humanos , Masculino , Estadiamento de Neoplasias , Prognóstico , Recidiva , Estudos Retrospectivos , Análise de Sobrevida , Transplante Autólogo , Resultado do Tratamento , Turquia/epidemiologia , Adulto Jovem
5.
Ann Clin Lab Sci ; 46(1): 26-31, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-26927339

RESUMO

PURPOSE: Doxorubicin (DXR) is an effective chemotherapeutic agent but causes severe cardiac failure over known doses. Thus, early detection and prevention of cardiac damage is important. Various markers have been tested for early detection of cardiac damage. Myostatin is a protein produced in skeletal muscle cells inhibits muscle differentiation and growth during myogenesis. METHODS: We evaluated the role of myostatin as a marker for showing DXR induced cardiac damage and compared with well known cardiac markers like NT-proBNP, hs-TnT and CK in a rat model of chronic DXR cardiotoxicity. RESULTS: Myostatin, NT-proBNP, and hs-TnT but not CK rose significantly during DXR treatment. CONCLUSION: Myostatin can be used as an early marker of DXR induced cardiotoxicity.


Assuntos
Doxorrubicina/efeitos adversos , Cardiopatias/sangue , Cardiopatias/induzido quimicamente , Miocárdio/patologia , Miostatina/sangue , Animais , Biomarcadores/sangue , Creatina Quinase/sangue , Cardiopatias/patologia , Masculino , Peptídeo Natriurético Encefálico/sangue , Oxidantes/metabolismo , Fragmentos de Peptídeos/sangue , Ratos Sprague-Dawley , Troponina T/sangue
6.
Int J Low Extrem Wounds ; 15(3): 248-54, 2016 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26286933

RESUMO

Doxorubicin (DXR) extravasation result with serious morbidity like skin ulceration and necrosis. The purpose of this study is to determine the protective effects of ozone, olive oil, dimethyl sulfoxide (DMSO), and coenzyme Q10 in the treatment of DXR-induced skin ulcers on rats. After an intradermal injection of DXR on a basis of an animal extravasation model, the materials were topically applied. The ulcer sizes were measured, and a punch biopsy was taken from the extravasation site in which the skin ulcers formed at the end of the experiment. The samples were analyzed for tumor necrosis factor alpha (TNF-α), interleukin 1-beta (IL1ß), malondialdehyde (MDA), superoxide dismutase (SOD), and glutathione peroxidase (GSH-Px) enzymes, and examined histopathologically. The ulcer sizes clearly decreased in the study groups, including DMSO, olive oil, ozone plus coenzyme Q10, and ozone plus olive oil groups in comparison with the control group with the exception of the coenzyme Q10 group. The malondialdehyde levels were lower in the DMSO, olive oil, ozone plus olive oil, and ozone plus coenzyme Q10 groups than they were in the control group, but they were not significantly different. The TNF-α level was lower in the DMSO, ozone plus olive oil, coenzyme Q10, and ozone plus coenzyme Q10 groups in comparison with the control group. There was no significant change in the SOD, GSH-Px, and IL1ß levels in the study groups in comparison with the control and the sham groups. The ozone plus olive oil group could be considered to be an alternate therapy for skin ulcers due to DXR extravasation.


Assuntos
Doxorrubicina/efeitos adversos , Extravasamento de Materiais Terapêuticos e Diagnósticos/complicações , Necrose , Azeite de Oliva/farmacologia , Ozônio/farmacologia , Úlcera Cutânea , Ubiquinona/análogos & derivados , Animais , Antibióticos Antineoplásicos/efeitos adversos , Antibióticos Antineoplásicos/farmacologia , Antioxidantes/farmacologia , Biópsia/métodos , Dimetil Sulfóxido , Modelos Animais de Doenças , Doxorrubicina/farmacologia , Necrose/induzido quimicamente , Necrose/metabolismo , Necrose/prevenção & controle , Estresse Oxidativo/efeitos dos fármacos , Ratos , Pele/efeitos dos fármacos , Pele/patologia , Úlcera Cutânea/complicações , Úlcera Cutânea/diagnóstico , Úlcera Cutânea/metabolismo , Úlcera Cutânea/terapia , Ubiquinona/farmacologia
7.
J Cancer Res Ther ; 11(3): 653, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26458636

RESUMO

Clofarabine is an effective drug in relapsed leukemia and lymphoma that has some adverse effects which can be fatal like capillary leak syndrome (CLS). Identification and management of CLS is important that may result in mortality. Although prophylactic treatment with steroids may prevent CLS and improve survival, intravenous immunoglobulins are used in the treatment with great success in steroid resistant cases. However, the knowledge about the effects and the dose of intravenous immunoglobulins (IVIG) in pediatric patients is limited. Herein, we reported a patient with relapsed lymphoma who developed CLS successfully and was treated with IVIG.


Assuntos
Nucleotídeos de Adenina/efeitos adversos , Arabinonucleosídeos/efeitos adversos , Imunoglobulinas Intravenosas/administração & dosagem , Linfoma/tratamento farmacológico , Síndrome de Vazamento Capilar/induzido quimicamente , Pré-Escolar , Clofarabina , Humanos , Linfoma/complicações , Linfoma/patologia , Masculino
8.
J Cancer Res Ther ; 11(3): 666, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26458705

RESUMO

There are a lot of early or late side effects of chemotherapies. One of them is Raynaud's phenomenon (RP). Vascular toxicity associated with antineoplastic agents is notified in bleomycin alone therapy or in combination with cisplatin, vinblastine, and vincristine. The mechanism of RP associated with antineoplastic agents is unknown. All children receiving vinblastine, vincristine, bleomycin and cisplatin therapy, are followed and questioned about their complaint on RP. Long-term follow-up of surviving patients is recommended. Oncologists should be aware of the potential late toxic effects of antineoplastic drugs.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos , Neoplasias Cerebelares/diagnóstico , Meduloblastoma/diagnóstico , Doença de Raynaud/diagnóstico , Adolescente , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias Cerebelares/terapia , Quimiorradioterapia , Cisplatino/administração & dosagem , Feminino , Dedos/irrigação sanguínea , Humanos , Lomustina/administração & dosagem , Meduloblastoma/terapia , Doença de Raynaud/induzido quimicamente , Dedos do Pé/irrigação sanguínea , Vincristina/administração & dosagem
9.
J Cancer Res Ther ; 11(3): 667, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26458707

RESUMO

After hematopoietic stem cell transplantation (HSCT), patients may suffer from bleeding. One of the bleeding type is gastrointestinal (GI) which has serious morbidity and mortality in children with limited treatment options. Herein, we presented a child with upper GI bleeding post autologous HSCT controlled successfully by using recombinant activated factor VII (rFVIIa) and octreotide infusion.


Assuntos
Tumor do Seio Endodérmico/diagnóstico , Fator VIIa/uso terapêutico , Hemorragia Gastrointestinal/diagnóstico , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Octreotida/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Autoenxertos , Criança , Terapia Combinada , Tumor do Seio Endodérmico/terapia , Feminino , Hemorragia Gastrointestinal/tratamento farmacológico , Hemorragia Gastrointestinal/etiologia , Humanos
10.
J Cancer Res Ther ; 11(3): 668, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26458714

RESUMO

Chemotherapy regimens, including doxorubicin used in primitive neuroectodermal tumor's (PNET) treatment can cause life-threatening disorders in cardiac functions. Follow-up of cardiac functions in the clinical course is very important during treatment with ejection fraction (EF) and shortening fraction (SF). However, sometimes the detection of cardiac failure with EF and SF cannot be possible. In this condition, we may need new evaluation test. Herein, we wanted to present a child with PNET of the chest wall suffered from antracycline toxicity and indicate that close monitoring of cardiac function could be important.


Assuntos
Antraciclinas/efeitos adversos , Neoplasias Encefálicas/diagnóstico por imagem , Tumores Neuroectodérmicos Primitivos/diagnóstico por imagem , Neoplasias Torácicas/diagnóstico por imagem , Antraciclinas/uso terapêutico , Neoplasias Encefálicas/tratamento farmacológico , Neoplasias Encefálicas/secundário , Pré-Escolar , Evolução Fatal , Feminino , Humanos , Tumores Neuroectodérmicos Primitivos/tratamento farmacológico , Tumores Neuroectodérmicos Primitivos/secundário , Radiografia , Neoplasias Torácicas/tratamento farmacológico , Neoplasias Torácicas/patologia , Parede Torácica/patologia
11.
Pediatr Transplant ; 19(7): 745-52, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26346042

RESUMO

This study evaluates the outcome of 66 pediatric patients with rrHL who underwent autoHSCT. Twenty-nine patients experienced early relapse, and 19 patients experienced late relapse. Of 18 newly diagnosed with HL, 13 were primary refractory disease and five had late responsive disease. At the time of transplantation, only 68% of the patients were chemosensitive. The majority of patients received BCNU + etoposide + ara-C + melphalan for conditioning (45/66), and peripheral blood (56/66) was used as a source of stem cells. After a median follow-up period of 39 months, 46 patients were alive. At five yr, the probabilities of OS, EFS, the relapse rate, and the non-relapse mortality rate were 63.1%, 54.3%, 36.4%, and 9.1%, respectively. The probability of EFS in chemosensitive and chemoresistant patients at five yr was 72.3% and 19%, respectively (p < 0.001). Multivariate analysis showed that chemoresistant disease at the time of transplantation was the only factor predicting limited both OS (hazard ratio = 4.073) and EFS (hazard ratio = 4.599). AutoHSCT plays an important role for the treatment of rrHL in children and adolescents, and survival rates are better for patients with chemosensitive disease at the time of transplantation.


Assuntos
Transplante de Células-Tronco Hematopoéticas , Doença de Hodgkin/terapia , Adolescente , Criança , Feminino , Seguimentos , Doença de Hodgkin/mortalidade , Humanos , Masculino , Modelos de Riscos Proporcionais , Recidiva , Estudos Retrospectivos , Transplante Autólogo , Resultado do Tratamento , Adulto Jovem
12.
J Cancer Res Ther ; 11(2): 268-71, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26148582

RESUMO

CONTEXT: Surgery is an important part of treatment in children with neuroblastoma; however, exact timing is unclear. Both initial and delayed surgery was suggested as the best by numerous studies. AIMS: Thus, we aimed to investigate the role of delayed surgery on 31 children with high-risk neuroblastoma. MATERIALS AND METHODS: Thirty-one children with high-risk neuroblastoma were enrolled into the study. STATISTICAL ANALYSIS USED: Statistical analysis was performed using Statistical Package for the Social Sciences (SPSS) for windows 10.0. RESULTS: There 'were 15 male and 16 female patients with a median age of 3.0 ± 3.2 years. Primary tumor site was adrenal in 27, non-adrenal in two, pelvic in one, and mediastinal in one patient. MYCN gene was amplified in four and non-amplified in 11 children on totally 15 children with available data. Lactate dehydrogenase was elevated in 30 children. The tumor volumes at diagnosis and before surgery in the whole group were 154.3 and 12.5 mL, respectively. The decline in tumor volume was statistically significant (P < 0.0001). Initial surgery was performed in three and delayed in 20 children, and eight children were inoperable. Surgical complication rate was 66.6% (two out of three patients) in initial surgery group; however, the rate was 15% (3 out of 20 patients) in delayed surgery group. The 5-year event-free survival and overall survival rates in the whole group were 44.8% and 50.8%, respectively. Primary tumor area control rate was 95% CONCLUSIONS: In conclusion, the delayed surgery with intensive chemotherapy and radiotherapy has been successful for primary control in high-risk neuroblastoma patients.


Assuntos
Neuroblastoma/patologia , Neuroblastoma/cirurgia , Fatores Etários , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Biomarcadores Tumorais , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Recém-Nascido , Masculino , Estadiamento de Neoplasias , Neuroblastoma/tratamento farmacológico , Neuroblastoma/mortalidade , Complicações Pós-Operatórias , Retratamento , Fatores de Tempo , Resultado do Tratamento
14.
Helicobacter ; 20(6): 418-21, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25856798

RESUMO

BACKGROUND: Anticardiolipin (aCL) antibodies are associated with thrombosis and have an important role in the etiology of diseases such as stroke and myocardial infarction whose etiologies were based on thrombosis. H. pylori has been proposed to be responsible for the pathophysiology of some diseases including stroke, myocardial infarction, thrombosis, and autoimmune diseases. From this point of view, we hypothesized a possible relationship between H. pylori infection and aCL antibodies and initially aimed to determine the prevalence of aCL antibody positivity in children with H. pylori infection. MATERIALS AND METHODS: Anticardiolipin antibodies were studied in 84 patients before and after eradication therapy and in a control group including 40 children. RESULTS: The pretreatment aCL IgA (median 12.78 APL/mL), aCL IgM (median 21.60 MPL/mL), and aCL IgG antibody levels (median 14.22 GPL/mL) were significantly higher than those of post-treatment results (median 5.38 APL/mL, 7.02 MPL/mL, and 6.64 GPL/mL, respectively) and controls (median 5.90 APL/mL, 4.80 MPL/mL, and 4.81 GPL/mL, respectively). Anticardiolipin antibodies revealed no significant differences between the study group after therapy and the control group. CONCLUSIONS: In our particular experience, H. pylori can cause aCL antibody positivity in children and eradication of H. pylori provides the disappearance of these antibodies.


Assuntos
Anticorpos Anticardiolipina/sangue , Infecções por Helicobacter/patologia , Helicobacter pylori/patogenicidade , Adolescente , Criança , Feminino , Humanos , Masculino
15.
Adv Med Sci ; 60(2): 199-203, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25847177

RESUMO

PURPOSE: Necrotizing enterocolitis (NEC) is a severe disease of mostly premature infants with high morbidity and mortality rates. There is no reliable biomarker for detecting newborns at risk for NEC development. We aimed to investigate small intestinal lactoferrin (LF) and calprotectin (CAL) levels as predictors and indicators of disease severity in an experimental newborn rat model. MATERIALS AND METHODS: Newborn pups were randomly divided into two groups, NEC and control. The NEC group pups were decapitated on the second, third and fourth days of the experiment for an assessment of the different stages of NEC. In the study group, hypoxia-reoxygenation model used to induce NEC. As biochemical parameters, small intestinal LF and CAL levels were measured with an enzyme-linked immunosorbent assay technique and intestinal injury scoring was evaluated as a pathologic parameter. RESULTS: Small intestinal levels of both LF and CAL increased in the second and the third day groups, but began to decrease by the fourth day. The first, second and third day levels of LF and CAL were higher than controls. The intestinal injury scores of all NEC groups were significantly higher than the control group. CONCLUSION: Small intestinal lactoferrin and calprotectin were good markers for demonstrating NEC. However, instead of spot testing, monitoring the levels of these markers may be more informative.


Assuntos
Biomarcadores/metabolismo , Enterocolite Necrosante/metabolismo , Enterocolite Necrosante/patologia , Lactoferrina/metabolismo , Complexo Antígeno L1 Leucocitário/metabolismo , Animais , Animais Recém-Nascidos , Ensaio de Imunoadsorção Enzimática , Ratos
16.
Pediatr Transplant ; 19(4): 380-4, 2015 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25752654

RESUMO

Although ASCT is used as a standard treatment following second remission for adults in oncology practice, data are lacking for relapsed childhood HL. Therefore, we evaluated the exact timing of the ASCT treatment, as well as factors affecting the prognosis in children with relapsed HL who underwent ASCT. Patients were divided into two groups (Group 1: ASCT after second remission [n = 6], Group 2: ASCT after >2 remissions [n = 3]). Overall, DFS rate was 64.8% at 24 months after ASCT. In Group 1, post-transplant DFS and OS were 83.3% and 75%, respectively, and the post-transplant response without event rate was 5/6 (83.3%). However, in Group 2 this was 1/3 (33.3%). Nonetheless, the timing of ASCT was not a significant prognostic factor for DFS and OS in univariate analyses (p = 0.21 and p = 0.73, respectively). Median follow-up time was 21 months after transplant, and DFS and OS were 62.5% and 75% in early relapse group (n = 6) at 24 months. DFS and OS were both 66.7% in late relapse (n = 3). In addition, response rates of ASCT without event were 66.7% for both early and late relapse groups. Relapse types (early: 3-12 months, late: >12 months) was not a significant prognostic factor for DFS and OS in univariate analyses (p = 0.96 and p = 0.92). While we found ASCT to be a useful treatment following second remission, it does not demonstrate better success in early relapse cases, when compared to late relapse cases. Therefore, after second remission for relapsed HL, ASCT is advisable regardless of the time of relapse.


Assuntos
Doença de Hodgkin/patologia , Doença de Hodgkin/terapia , Transplante de Células-Tronco/métodos , Adolescente , Criança , Progressão da Doença , Feminino , Seguimentos , Humanos , Estimativa de Kaplan-Meier , Masculino , Prognóstico , Recidiva , Indução de Remissão , Estudos Retrospectivos , Fatores de Tempo
17.
J Cancer Res Ther ; 11(4): 882-6, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26881535

RESUMO

BACKGROUND: Cardiotoxicity, during or after therapy, is the most serious side effect of doxorubicin (DXR). The risk of developing cardiac impairment increases concomitantly with an increase in the cumulative dose of DXR. AIM: The aim was to evaluate the levels of cardiac troponin-I (cTnI), brain natriuretic peptide (BNP) and endothelin-1 (ET-1) in DXR induced cardiac injury. MATERIALS AND METHODS: Thirty-nine Wistar albino rats were divided into three groups; a control group and two-study groups that received low-dose DXR (LDD) and high-dose DXR (HDD) in a weekly schedule for reaching a cumulative dose. RESULTS: Serum cTnI level was significantly increased in both LDD and HDD-treated groups. Although serum BNP was not significantly increased either LDD or HDD-treated groups, ET-1 levels was significantly increased in only HDD-treated groups. Histopathologic injury was more evident in HDD-treated group. CONCLUSIONS: Serum cTnI was increased even in LDD and parallel to it low cardiac injury induced by DXR. In the low-dose group, BNP and ET-1 levels were not elevated significant as cTnI despite cardiac injury. Thus, cTnI may be a predictive marker in of DXR-induced cardiotoxicity.


Assuntos
Antibióticos Antineoplásicos/toxicidade , Biomarcadores/metabolismo , Doxorrubicina/toxicidade , Endotelina-1/metabolismo , Cardiopatias/metabolismo , Peptídeo Natriurético Encefálico/metabolismo , Troponina I/metabolismo , Animais , Ensaio de Imunoadsorção Enzimática , Cardiopatias/induzido quimicamente , Cardiopatias/patologia , Masculino , Ratos , Ratos Wistar
18.
J Cancer Res Ther ; 11(4): 1032, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26881621

RESUMO

Severe hyponatremia with seizure owing to the syndrome of inappropriate antidiuretic hormone secretion (SIADH) or cerebral/renal salt wasting syndrome related with high mortality. The correct diagnosis of the hyponatremia for each case is important because of the alteration of the treatment approach. SIADH is an important clinical manifestation that does not occur after all chemotherapy courses. We cannot estimate whether the disease will occur on, which course of the chemotherapy in this case.


Assuntos
Antineoplásicos/efeitos adversos , Neoplasias Ósseas/tratamento farmacológico , Cisplatino/efeitos adversos , Hiponatremia/induzido quimicamente , Síndrome de Secreção Inadequada de HAD/induzido quimicamente , Osteossarcoma/tratamento farmacológico , Antineoplásicos/administração & dosagem , Neoplasias Ósseas/patologia , Pré-Escolar , Cisplatino/administração & dosagem , Humanos , Hiponatremia/patologia , Síndrome de Secreção Inadequada de HAD/patologia , Masculino , Osteossarcoma/patologia , Prognóstico
19.
J Pak Med Assoc ; 64(5): 514-8, 2014 May.
Artigo em Inglês | MEDLINE | ID: mdl-25272535

RESUMO

OBJECTIVE: To evaluate the prevalence and risk factors of tinea capitis and tinea pedis in school children in Turkey. METHODS: The study included 8122 students from 24 schools in the rural and urban areas around Kayseri,Turkey. We asked every student for their personal identification and also for their sanitation in order to get an idea about dermatophytosis. Samples taken from suspicious lesions were collected and inoculated onto Sabouraud dextrose agar slants. For identification of grown fungi, macroscopic appearance of colonies, microscopic examination and biochemical tests were used. RESULTS: There were 41 (0.5%) suspicious lesions in feet and 31 (0.3%) in scalp and 22 (0.2%) students were diagnosed as tinea pedis and 9 (0.1%) as tinea capitis by fungal culture. The predominant etiologic agents in feet were Trichophyton rubrum 8 (36%), Trichophyton mentagrophytes 1 (4%), Rhodotorula 8 (36%), Trichosporon 2 (9%), Candida glabrata 2 (9%), Candida albicans 1 (4%), while Trichophyton verrucosum 8 (88%) and Trichophyton mentagrophytes 1 (12%) were identified in scalp samples. School settlement was found as risk factors on the frequency of tinea pedis and capitis. Age and gender were also found as risk factors on the frequency of tinea pedis. CONCLUSION: The results of this study demonstrate a low prevalence of tinea capitis and tinea pedis in school children of central Anatolia of Turkey. School settlement is a very important factor affecting the prevalence of tinea capitis and pedis in school children in central Anatolia of Turkey.


Assuntos
Tinha do Couro Cabeludo/epidemiologia , Tinha dos Pés/epidemiologia , Adolescente , Criança , Pré-Escolar , Estudos Transversais , Feminino , Humanos , Modelos Logísticos , Masculino , Prevalência , Fatores de Risco , Estudantes , Tinha do Couro Cabeludo/microbiologia , Tinha dos Pés/microbiologia , Turquia/epidemiologia
20.
Syst Biol Reprod Med ; 60(6): 323-8, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25140409

RESUMO

Procarbazine (P) is an effective chemotherapeutic drug especially used in lymphoma treatment; however testicular toxicity is a limiting factor. Various ways of treatment were tried to preserve testicular function including hormonal treatment, antioxidant treatment, and sperm cryopreservation but resulted with low rates of satisfaction. Procarbazine is a well known agent causing sterility even in the first doses of chemotherapy. Antioxidants such as N acetylcysteine and ascorbate have been used for protective purposes and were very successful. Melatonin (M) is another powerful antioxidant and we aimed to use M for the protection of P induced testicular toxicity in this study. Procarbazine was given peroral by gavage once a week at a dose of 62.5 mg/kg/week for 4 weeks (total dose: 250 mg/kg) (P group) and in procarbazine + melatonin (PM) group, 10 mg/kg melatonin was intraperitoneally administered daily for five days a week for 4 weeks (total 20 days). The experiment ended at day 90. In the P and PM groups the testicle width, length, and weight, sperm A and sperm AB properties (Sperm A: sperms straight line progressive, Sperm B: sperms straight slow progressive, Sperm AB: Sperm A + Sperm B), spermatogonia, Sertoli cells, seminiferous tubule, and germinative layer thickness were lowered as compared with the control group. However, there were no significant differences between the P and PM groups in regard to these parameters. Melatonin preserved Sertoli cell and spermatogonia function. The testosterone and follicle-stimulating hormone (FSH) levels were also preserved. Melatonin significantly decreased malondialdehyde (MDA) levels and preserved the antioxidant enzyme levels such as glutathione peroxidase (GPx) and nitrite nitrate (NO2-/NO3-). Melatonin may protect testicular functions in P treated patients and is open to consideration during chemotherapy since it appears to be without any side effects.


Assuntos
Antineoplásicos , Antioxidantes/farmacologia , Melatonina/farmacologia , Procarbazina , Doenças Testiculares/prevenção & controle , Testículo/efeitos dos fármacos , Animais , Citoproteção , Modelos Animais de Doenças , Hormônio Foliculoestimulante/sangue , Glutationa Peroxidase/sangue , Masculino , Malondialdeído/sangue , Nitratos/sangue , Nitritos/sangue , Ratos Wistar , Células de Sertoli/efeitos dos fármacos , Células de Sertoli/metabolismo , Células de Sertoli/patologia , Motilidade dos Espermatozoides/efeitos dos fármacos , Espermatozoides/efeitos dos fármacos , Espermatozoides/patologia , Doenças Testiculares/sangue , Doenças Testiculares/induzido quimicamente , Doenças Testiculares/patologia , Testículo/metabolismo , Testículo/patologia , Testosterona/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...